Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS

Autor: R Channick, K M Chin, N H Kim, R Ong, S Turricchia, L Mitchell, V V McLaughlin

Publikováno v: European Heart Journal. 43

Background Guidelines for the management of pulmonary arterial hypertension (PAH) recommend early combination therapy of an endothelial receptor antagonist (ERA) and a phosphodiesterase type-5 inhibitor (PDE5i) [1]. There is, however, limited guidanc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a7092c3b3c6392cc03560c5e54dc6860
https://doi.org/10.1093/eurheartj/ehac544.1916

Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative

Autor: D, Khanna, Ma, Tan, D E, Furst, N S, Hill, V V, McLaughlin, R M, Silver, V D, Steen, A, Langer, J R, Seibold, Barbara, Segal

Publikováno v: Clinical and experimental rheumatology. 32(6 Suppl 86)

The aim of this study was to utilise the Quality Enhancement Research Initiative in Systemic Sclerosis (QuERI-SSc) to measure and reduce a perceived gap in the diagnosis of pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dd0854529d02e6e15a51dadcc8c030e6
https://pubmed.ncbi.nlm.nih.gov/24295227

Medicalsurgical approaches to pulmonary hypertension

Autor: V V, McLaughlin, S, Rich

Publikováno v: Comprehensive therapy. 23(9)

When no other explanation for pulmonary hypertension can be found, it is referred to as primary pulmonary hypertension (PPH). Causes of pulmonary hypertension, with a special focus on PPH, as well as recent advances in both its medical and surgical t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e384eb1d63719215eca01271c6e2748
https://pubmed.ncbi.nlm.nih.gov/9285162

Full Issue PDF.

Publikováno v: Advances in Pulmonary Hypertension. 2023, Vol. 22 Issue 4, p1-82. 82p.

Maintenance of Cardiac Microenvironmental Homeostasis: A Joint Battle of Multiple Cells.

Autor: Yao J; School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China., Zhang Y; School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China., Wang Z; School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China., Chen Y; School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China., Shi X; School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China.

Publikováno v: Journal of cellular physiology [J Cell Physiol] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.